派林生物 (000403.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(派林生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 665,741,511.82448,211,537.95260,860,262.39911,716,158.60502,420,210.40490,631,423.38500,420,632.99
 营业收入(元) 665,741,511.82448,211,537.95260,860,262.39911,716,158.60502,420,210.40490,631,423.38500,420,632.99
二、营业总成本(元) 460,920,487.23354,039,739.30218,309,593.81646,584,075.58367,294,110.81354,997,268.81384,458,625.31
 营业成本(元) 323,326,734.70228,838,569.41134,577,337.57399,835,943.75230,036,548.57249,411,609.91272,159,168.06
 研发费用(元) 24,386,868.7915,100,147.1214,274,385.6431,240,073.6218,855,824.6810,694,320.0714,574,604.59
 营业税金及附加(元) 5,080,739.113,817,680.502,812,960.956,163,993.983,545,048.613,202,794.583,883,278.86
 销售费用(元) 81,243,780.8879,579,892.7441,433,502.19182,055,572.7189,038,333.8258,653,912.1569,820,970.43
 管理费用(元) 40,340,382.4442,445,015.4538,862,602.3143,731,968.9139,091,016.1646,005,803.8536,648,226.79
 财务费用(元) -13,458,018.69-15,741,565.92-13,651,194.85-16,443,477.39-13,272,661.03-12,971,171.75-12,627,623.42
  其中:利息费用(元) 1,722,803.462,015,909.412,457,191.153,857,666.632,482,277.332,990,707.872,695,047.56
  其中:利息收入(元) 16,239,026.5317,640,329.7916,440,642.5716,325,571.2117,073,834.2516,306,894.5815,472,842.61
 信用减值损失(元) -904,603.14-3,091,710.2712,061,663.28-7,614,118.6153,548.82-3,803,224.09-452,725.42
三、其他经营收益
 加:公允价值变动收益(元) 3,291,321.682,920,566.162,735,457.882,110,461.652,475,230.85-1,115,738.661,459,166.67
 加:投资收益(元) 1,763,391.761,977,094.43616,694.45404,478.571,037,723.66475,387.431,120,250.01
 资产处置收益(元) -11,485.14538.03304.27446,550.27-12,587.653,815.80
 其他收益(元) 2,300,912.252,200,801.535,208,458.905,058,829.715,759,855.332,032,275.482,011,260.38
四、营业利润(元) 211,272,047.1498,190,035.6463,173,481.12265,216,445.37144,899,008.52133,210,267.08120,103,775.12
 加:营业外收入(元) 2,208,255.631,074,944.63190.432,374,887.30438.61139,862.991.22
 减:营业外支出(元) 2,740,629.262,852,553.21256,781.203,734,537.84335,994.46354,778.191,127,236.59
五、利润总额(元) 210,739,673.5196,412,427.0662,916,890.35263,856,794.83144,563,452.67132,995,351.88118,976,539.75
 减:所得税费用(元) 27,927,352.669,629,745.046,698,573.4326,711,767.0715,609,751.9217,407,631.3612,972,848.55
六、净利润(元) 182,812,320.8586,782,682.0256,218,316.92237,145,027.76128,953,700.75115,587,720.52106,003,691.20
(一)按经营持续性分类
  持续经营净利润(元) 182,812,320.8586,782,682.0256,218,316.92237,145,027.76128,953,700.75115,587,720.52106,003,691.20
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 183,058,248.3086,761,083.9856,376,087.53237,592,037.11128,533,560.22115,401,490.69105,604,403.84
  少数股东损益(元) -245,927.4521,598.04-157,770.61-447,009.35420,140.53186,229.83399,287.36
 扣除非经常性损益后的净利润(元) 165,517,541.6267,973,005.9936,249,382.73218,500,528.16107,217,661.85101,837,970.2790,018,691.14
七、每股收益
 一、基本每股收益(元) 0.250.120.080.330.180.160.14
 二、稀释每股收益(元) 0.250.120.080.330.180.160.14
八、其他综合收益(元) -4,583.0934,710.75-9,140.31-41,005.3066,593.734,156.205,897.52
 归属于母公司股东的其他综合收益(元) -4,583.0934,710.75-9,140.31-41,005.3066,593.734,156.205,897.52
九、综合收益总额(元) 182,807,737.7686,817,392.7756,209,176.61237,104,022.46129,020,294.48115,591,876.72106,009,588.72
 归属于母公司所有者的综合收益总额(元) 183,053,665.2186,795,794.7356,366,947.22237,551,031.81128,600,153.95115,405,646.89105,610,301.36
 归属于少数股东的综合收益总额(元) -245,927.4521,598.04-157,770.61-447,009.35420,140.53186,229.83399,287.36
公告日期 2023-10-312023-08-242023-04-292023-04-292022-10-312022-08-302022-04-30
审计意见(境内) 标准无保留意见

前瞻产业研究院